English
简体中文
Total: £ 56.28
Published Date: 2024-04-07 | Pages: 137 | Tables: 253 | Pharma & Healthcare
Pain Therapeutic Injectable is administered directly into the joint, where they are formulated to reduce inflammation and pain. Once injected into the joint, pain relief is almost immediate.
The global market for Pain Therapeutic Injection was estimated to be worth US$ 19300 million in 2023 and is forecast to a readjusted size of US$ 26240 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pain Therapeutic Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pain Therapeutic Injection by region & country, by Type, and by Application.
The Pain Therapeutic Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Therapeutic Injection.
Market Segmentation
By Company
AbbVie Inc.
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd.
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Bayer AG
F. Hoffmann-La Roche Ltd.
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Segment by Type:
OTC Drugs
Prescription Drugs
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pain Therapeutic Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pain Therapeutic Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pain Therapeutic Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Pain Therapeutic Injection Product Introduction
1.2 Global Pain Therapeutic Injection Market Size Forecast
1.2.1 Global Pain Therapeutic Injection Sales Value (2019-2030)
1.2.2 Global Pain Therapeutic Injection Sales Volume (2019-2030)
1.2.3 Global Pain Therapeutic Injection Sales Price (2019-2030)
1.3 Pain Therapeutic Injection Market Trends & Drivers
1.3.1 Pain Therapeutic Injection Industry Trends
1.3.2 Pain Therapeutic Injection Market Drivers & Opportunity
1.3.3 Pain Therapeutic Injection Market Challenges
1.3.4 Pain Therapeutic Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pain Therapeutic Injection Players Revenue Ranking (2023)
2.2 Global Pain Therapeutic Injection Revenue by Company (2019-2024)
2.3 Global Pain Therapeutic Injection Players Sales Volume Ranking (2023)
2.4 Global Pain Therapeutic Injection Sales Volume by Company Players (2019-2024)
2.5 Global Pain Therapeutic Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers Pain Therapeutic Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pain Therapeutic Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pain Therapeutic Injection
2.9 Pain Therapeutic Injection Market Competitive Analysis
2.9.1 Pain Therapeutic Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pain Therapeutic Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Therapeutic Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 OTC Drugs
3.1.2 Prescription Drugs
3.2 Global Pain Therapeutic Injection Sales Value by Type
3.2.1 Global Pain Therapeutic Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pain Therapeutic Injection Sales Value, by Type (2019-2030)
3.2.3 Global Pain Therapeutic Injection Sales Value, by Type (%) (2019-2030)
3.3 Global Pain Therapeutic Injection Sales Volume by Type
3.3.1 Global Pain Therapeutic Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pain Therapeutic Injection Sales Volume, by Type (2019-2030)
3.3.3 Global Pain Therapeutic Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global Pain Therapeutic Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Pain Therapeutic Injection Sales Value by Application
4.2.1 Global Pain Therapeutic Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pain Therapeutic Injection Sales Value, by Application (2019-2030)
4.2.3 Global Pain Therapeutic Injection Sales Value, by Application (%) (2019-2030)
4.3 Global Pain Therapeutic Injection Sales Volume by Application
4.3.1 Global Pain Therapeutic Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pain Therapeutic Injection Sales Volume, by Application (2019-2030)
4.3.3 Global Pain Therapeutic Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global Pain Therapeutic Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pain Therapeutic Injection Sales Value by Region
5.1.1 Global Pain Therapeutic Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pain Therapeutic Injection Sales Value by Region (2019-2024)
5.1.3 Global Pain Therapeutic Injection Sales Value by Region (2025-2030)
5.1.4 Global Pain Therapeutic Injection Sales Value by Region (%), (2019-2030)
5.2 Global Pain Therapeutic Injection Sales Volume by Region
5.2.1 Global Pain Therapeutic Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pain Therapeutic Injection Sales Volume by Region (2019-2024)
5.2.3 Global Pain Therapeutic Injection Sales Volume by Region (2025-2030)
5.2.4 Global Pain Therapeutic Injection Sales Volume by Region (%), (2019-2030)
5.3 Global Pain Therapeutic Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pain Therapeutic Injection Sales Value, 2019-2030
5.4.2 North America Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pain Therapeutic Injection Sales Value, 2019-2030
5.5.2 Europe Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pain Therapeutic Injection Sales Value, 2019-2030
5.6.2 Asia Pacific Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pain Therapeutic Injection Sales Value, 2019-2030
5.7.2 South America Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pain Therapeutic Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pain Therapeutic Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pain Therapeutic Injection Sales Value
6.2.1 Key Countries/Regions Pain Therapeutic Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pain Therapeutic Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pain Therapeutic Injection Sales Value, 2019-2030
6.3.2 United States Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pain Therapeutic Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pain Therapeutic Injection Sales Value, 2019-2030
6.4.2 Europe Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pain Therapeutic Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pain Therapeutic Injection Sales Value, 2019-2030
6.5.2 China Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pain Therapeutic Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pain Therapeutic Injection Sales Value, 2019-2030
6.6.2 Japan Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pain Therapeutic Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pain Therapeutic Injection Sales Value, 2019-2030
6.7.2 South Korea Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pain Therapeutic Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pain Therapeutic Injection Sales Value, 2019-2030
6.8.2 Southeast Asia Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pain Therapeutic Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pain Therapeutic Injection Sales Value, 2019-2030
6.9.2 India Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pain Therapeutic Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Company Information
7.1.2 AbbVie Inc. Introduction and Business Overview
7.1.3 AbbVie Inc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie Inc. Pain Therapeutic Injection Product Offerings
7.1.5 AbbVie Inc. Recent Development
7.2 Bristol Myers Squibb Co.
7.2.1 Bristol Myers Squibb Co. Company Information
7.2.2 Bristol Myers Squibb Co. Introduction and Business Overview
7.2.3 Bristol Myers Squibb Co. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bristol Myers Squibb Co. Pain Therapeutic Injection Product Offerings
7.2.5 Bristol Myers Squibb Co. Recent Development
7.3 Sanofi S.A.
7.3.1 Sanofi S.A. Company Information
7.3.2 Sanofi S.A. Introduction and Business Overview
7.3.3 Sanofi S.A. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sanofi S.A. Pain Therapeutic Injection Product Offerings
7.3.5 Sanofi S.A. Recent Development
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Company Information
7.4.2 Boehringer Ingelheim International GmbH Introduction and Business Overview
7.4.3 Boehringer Ingelheim International GmbH Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boehringer Ingelheim International GmbH Pain Therapeutic Injection Product Offerings
7.4.5 Boehringer Ingelheim International GmbH Recent Development
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Company Information
7.5.2 Pfizer Inc. Introduction and Business Overview
7.5.3 Pfizer Inc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Pfizer Inc. Pain Therapeutic Injection Product Offerings
7.5.5 Pfizer Inc. Recent Development
7.6 Zydus Lifesciences Ltd.
7.6.1 Zydus Lifesciences Ltd. Company Information
7.6.2 Zydus Lifesciences Ltd. Introduction and Business Overview
7.6.3 Zydus Lifesciences Ltd. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Zydus Lifesciences Ltd. Pain Therapeutic Injection Product Offerings
7.6.5 Zydus Lifesciences Ltd. Recent Development
7.7 GSK plc.
7.7.1 GSK plc. Company Information
7.7.2 GSK plc. Introduction and Business Overview
7.7.3 GSK plc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.7.4 GSK plc. Pain Therapeutic Injection Product Offerings
7.7.5 GSK plc. Recent Development
7.8 Abbott Laboratories, Inc.
7.8.1 Abbott Laboratories, Inc. Company Information
7.8.2 Abbott Laboratories, Inc. Introduction and Business Overview
7.8.3 Abbott Laboratories, Inc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Abbott Laboratories, Inc. Pain Therapeutic Injection Product Offerings
7.8.5 Abbott Laboratories, Inc. Recent Development
7.9 Novartis AG
7.9.1 Novartis AG Company Information
7.9.2 Novartis AG Introduction and Business Overview
7.9.3 Novartis AG Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Novartis AG Pain Therapeutic Injection Product Offerings
7.9.5 Novartis AG Recent Development
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Information
7.10.2 Johnson & Johnson Introduction and Business Overview
7.10.3 Johnson & Johnson Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Johnson & Johnson Pain Therapeutic Injection Product Offerings
7.10.5 Johnson & Johnson Recent Development
7.11 Teva Pharmaceuticals Ltd.
7.11.1 Teva Pharmaceuticals Ltd. Company Information
7.11.2 Teva Pharmaceuticals Ltd. Introduction and Business Overview
7.11.3 Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Product Offerings
7.11.5 Teva Pharmaceuticals Ltd. Recent Development
7.12 Mallinckrodt Pharmaceuticals
7.12.1 Mallinckrodt Pharmaceuticals Company Information
7.12.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
7.12.3 Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Product Offerings
7.12.5 Mallinckrodt Pharmaceuticals Recent Development
7.13 Bayer AG
7.13.1 Bayer AG Company Information
7.13.2 Bayer AG Introduction and Business Overview
7.13.3 Bayer AG Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Bayer AG Pain Therapeutic Injection Product Offerings
7.13.5 Bayer AG Recent Development
7.14 F. Hoffmann-La Roche Ltd.
7.14.1 F. Hoffmann-La Roche Ltd. Company Information
7.14.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
7.14.3 F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.14.4 F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Product Offerings
7.14.5 F. Hoffmann-La Roche Ltd. Recent Development
7.15 AstraZeneca
7.15.1 AstraZeneca Company Information
7.15.2 AstraZeneca Introduction and Business Overview
7.15.3 AstraZeneca Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.15.4 AstraZeneca Pain Therapeutic Injection Product Offerings
7.15.5 AstraZeneca Recent Development
7.16 Cardinal Health
7.16.1 Cardinal Health Company Information
7.16.2 Cardinal Health Introduction and Business Overview
7.16.3 Cardinal Health Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Cardinal Health Pain Therapeutic Injection Product Offerings
7.16.5 Cardinal Health Recent Development
7.17 Perrigo Company Plc.
7.17.1 Perrigo Company Plc. Company Information
7.17.2 Perrigo Company Plc. Introduction and Business Overview
7.17.3 Perrigo Company Plc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Perrigo Company Plc. Pain Therapeutic Injection Product Offerings
7.17.5 Perrigo Company Plc. Recent Development
7.18 Bausch Health Companies Inc.
7.18.1 Bausch Health Companies Inc. Company Information
7.18.2 Bausch Health Companies Inc. Introduction and Business Overview
7.18.3 Bausch Health Companies Inc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Bausch Health Companies Inc. Pain Therapeutic Injection Product Offerings
7.18.5 Bausch Health Companies Inc. Recent Development
8 Industry Chain Analysis
8.1 Pain Therapeutic Injection Industrial Chain
8.2 Pain Therapeutic Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pain Therapeutic Injection Sales Model
8.5.2 Sales Channel
8.5.3 Pain Therapeutic Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Pain Therapeutic Injection Market Trends
Table 2. Pain Therapeutic Injection Market Drivers & Opportunity
Table 3. Pain Therapeutic Injection Market Challenges
Table 4. Pain Therapeutic Injection Market Restraints
Table 5. Global Pain Therapeutic Injection Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Pain Therapeutic Injection Revenue Market Share by Company (2019-2024)
Table 7. Global Pain Therapeutic Injection Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Pain Therapeutic Injection Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Pain Therapeutic Injection Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Pain Therapeutic Injection Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Pain Therapeutic Injection Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Pain Therapeutic Injection
Table 13. Global Pain Therapeutic Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Therapeutic Injection as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pain Therapeutic Injection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Pain Therapeutic Injection Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Pain Therapeutic Injection Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Pain Therapeutic Injection Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Pain Therapeutic Injection Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Pain Therapeutic Injection Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Pain Therapeutic Injection Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Pain Therapeutic Injection Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Pain Therapeutic Injection Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Pain Therapeutic Injection Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Pain Therapeutic Injection Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Pain Therapeutic Injection Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Pain Therapeutic Injection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Pain Therapeutic Injection Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Pain Therapeutic Injection Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Pain Therapeutic Injection Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Pain Therapeutic Injection Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Pain Therapeutic Injection Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Pain Therapeutic Injection Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Pain Therapeutic Injection Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Pain Therapeutic Injection Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Pain Therapeutic Injection Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Pain Therapeutic Injection Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Pain Therapeutic Injection Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Pain Therapeutic Injection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Pain Therapeutic Injection Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Pain Therapeutic Injection Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Pain Therapeutic Injection Sales Value by Region (2019-2024) & (%)
Table 44. Global Pain Therapeutic Injection Sales Value by Region (2025-2030) & (%)
Table 45. Global Pain Therapeutic Injection Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Pain Therapeutic Injection Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Pain Therapeutic Injection Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Pain Therapeutic Injection Sales Volume by Region (2019-2024) & (%)
Table 49. Global Pain Therapeutic Injection Sales Volume by Region (2025-2030) & (%)
Table 50. Global Pain Therapeutic Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Pain Therapeutic Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Pain Therapeutic Injection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Pain Therapeutic Injection Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Pain Therapeutic Injection Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Pain Therapeutic Injection Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Pain Therapeutic Injection Sales Volume, (2025-2030) & (K Units)
Table 57. AbbVie Inc. Company Information
Table 58. AbbVie Inc. Introduction and Business Overview
Table 59. AbbVie Inc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. AbbVie Inc. Pain Therapeutic Injection Product Offerings
Table 61. AbbVie Inc. Recent Development
Table 62. Bristol Myers Squibb Co. Company Information
Table 63. Bristol Myers Squibb Co. Introduction and Business Overview
Table 64. Bristol Myers Squibb Co. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Bristol Myers Squibb Co. Pain Therapeutic Injection Product Offerings
Table 66. Bristol Myers Squibb Co. Recent Development
Table 67. Sanofi S.A. Company Information
Table 68. Sanofi S.A. Introduction and Business Overview
Table 69. Sanofi S.A. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Sanofi S.A. Pain Therapeutic Injection Product Offerings
Table 71. Sanofi S.A. Recent Development
Table 72. Boehringer Ingelheim International GmbH Company Information
Table 73. Boehringer Ingelheim International GmbH Introduction and Business Overview
Table 74. Boehringer Ingelheim International GmbH Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Boehringer Ingelheim International GmbH Pain Therapeutic Injection Product Offerings
Table 76. Boehringer Ingelheim International GmbH Recent Development
Table 77. Pfizer Inc. Company Information
Table 78. Pfizer Inc. Introduction and Business Overview
Table 79. Pfizer Inc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Pfizer Inc. Pain Therapeutic Injection Product Offerings
Table 81. Pfizer Inc. Recent Development
Table 82. Zydus Lifesciences Ltd. Company Information
Table 83. Zydus Lifesciences Ltd. Introduction and Business Overview
Table 84. Zydus Lifesciences Ltd. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Zydus Lifesciences Ltd. Pain Therapeutic Injection Product Offerings
Table 86. Zydus Lifesciences Ltd. Recent Development
Table 87. GSK plc. Company Information
Table 88. GSK plc. Introduction and Business Overview
Table 89. GSK plc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. GSK plc. Pain Therapeutic Injection Product Offerings
Table 91. GSK plc. Recent Development
Table 92. Abbott Laboratories, Inc. Company Information
Table 93. Abbott Laboratories, Inc. Introduction and Business Overview
Table 94. Abbott Laboratories, Inc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Abbott Laboratories, Inc. Pain Therapeutic Injection Product Offerings
Table 96. Abbott Laboratories, Inc. Recent Development
Table 97. Novartis AG Company Information
Table 98. Novartis AG Introduction and Business Overview
Table 99. Novartis AG Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Novartis AG Pain Therapeutic Injection Product Offerings
Table 101. Novartis AG Recent Development
Table 102. Johnson & Johnson Company Information
Table 103. Johnson & Johnson Introduction and Business Overview
Table 104. Johnson & Johnson Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Johnson & Johnson Pain Therapeutic Injection Product Offerings
Table 106. Johnson & Johnson Recent Development
Table 107. Teva Pharmaceuticals Ltd. Company Information
Table 108. Teva Pharmaceuticals Ltd. Introduction and Business Overview
Table 109. Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Product Offerings
Table 111. Teva Pharmaceuticals Ltd. Recent Development
Table 112. Mallinckrodt Pharmaceuticals Company Information
Table 113. Mallinckrodt Pharmaceuticals Introduction and Business Overview
Table 114. Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Product Offerings
Table 116. Mallinckrodt Pharmaceuticals Recent Development
Table 117. Bayer AG Company Information
Table 118. Bayer AG Introduction and Business Overview
Table 119. Bayer AG Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Bayer AG Pain Therapeutic Injection Product Offerings
Table 121. Bayer AG Recent Development
Table 122. F. Hoffmann-La Roche Ltd. Company Information
Table 123. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 124. F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Product Offerings
Table 126. F. Hoffmann-La Roche Ltd. Recent Development
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Introduction and Business Overview
Table 129. AstraZeneca Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. AstraZeneca Pain Therapeutic Injection Product Offerings
Table 131. AstraZeneca Recent Development
Table 132. Cardinal Health Company Information
Table 133. Cardinal Health Introduction and Business Overview
Table 134. Cardinal Health Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Cardinal Health Pain Therapeutic Injection Product Offerings
Table 136. Cardinal Health Recent Development
Table 137. Perrigo Company Plc. Company Information
Table 138. Perrigo Company Plc. Introduction and Business Overview
Table 139. Perrigo Company Plc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Perrigo Company Plc. Pain Therapeutic Injection Product Offerings
Table 141. Perrigo Company Plc. Recent Development
Table 142. Bausch Health Companies Inc. Company Information
Table 143. Bausch Health Companies Inc. Introduction and Business Overview
Table 144. Bausch Health Companies Inc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Bausch Health Companies Inc. Pain Therapeutic Injection Product Offerings
Table 146. Bausch Health Companies Inc. Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Pain Therapeutic Injection Downstream Customers
Table 150. Pain Therapeutic Injection Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Pain Therapeutic Injection Product Picture
Figure 2. Global Pain Therapeutic Injection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pain Therapeutic Injection Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Pain Therapeutic Injection Sales Volume (2019-2030) & (K Units)
Figure 5. Global Pain Therapeutic Injection Sales Price (2019-2030) & (US$/Unit)
Figure 6. Pain Therapeutic Injection Report Years Considered
Figure 7. Global Pain Therapeutic Injection Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Pain Therapeutic Injection Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pain Therapeutic Injection Revenue in 2023
Figure 10. Pain Therapeutic Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. OTC Drugs Picture
Figure 12. Prescription Drugs Picture
Figure 13. Global Pain Therapeutic Injection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Pain Therapeutic Injection Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Pain Therapeutic Injection Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Pain Therapeutic Injection Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Pain Therapeutic Injection Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital Pharmacies
Figure 19. Product Picture of Retail Pharmacies
Figure 20. Product Picture of Online Pharmacies
Figure 21. Global Pain Therapeutic Injection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Pain Therapeutic Injection Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Pain Therapeutic Injection Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Pain Therapeutic Injection Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Pain Therapeutic Injection Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Pain Therapeutic Injection Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Pain Therapeutic Injection Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Pain Therapeutic Injection Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Pain Therapeutic Injection Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Pain Therapeutic Injection Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Pain Therapeutic Injection Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Pain Therapeutic Injection Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Pain Therapeutic Injection Sales Volume (%), (2019-2030)
Figure 38. United States Pain Therapeutic Injection Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Pain Therapeutic Injection Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Pain Therapeutic Injection Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Pain Therapeutic Injection Sales Value by Application (%), 2023 VS 2030
Figure 44. China Pain Therapeutic Injection Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
Figure 46. China Pain Therapeutic Injection Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Pain Therapeutic Injection Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Pain Therapeutic Injection Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Pain Therapeutic Injection Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Pain Therapeutic Injection Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Pain Therapeutic Injection Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Pain Therapeutic Injection Sales Value by Application (%), 2023 VS 2030
Figure 56. India Pain Therapeutic Injection Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Pain Therapeutic Injection Sales Value by Type (%), 2023 VS 2030
Figure 58. India Pain Therapeutic Injection Sales Value by Application (%), 2023 VS 2030
Figure 59. Pain Therapeutic Injection Industrial Chain
Figure 60. Pain Therapeutic Injection Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
